These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31927712)

  • 1. Comment on "Cardiovascular risk stratification and appropriate use of statins in patients with systemic lupus erythematosus according to different strategies".
    Cure E; Cumhur Cure M
    Clin Rheumatol; 2020 Feb; 39(2):615-616. PubMed ID: 31927712
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular risk stratification and appropriate use of statins in patients with systemic lupus erythematosus according to different strategies.
    Masson W; Rossi E; Mora-Crespo LM; Cornejo-Peña G; Pessio C; Gago M; Alvarado RN; Scolnik M
    Clin Rheumatol; 2020 Feb; 39(2):455-462. PubMed ID: 31802350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risks and benefits of statins in lupus erythematosus.
    Noël B
    Arch Intern Med; 2004 Jan; 164(1):107-8. PubMed ID: 14718334
    [No Abstract]   [Full Text] [Related]  

  • 4. Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review.
    Fasano S; Margiotta DP; Navarini L; Pierro L; Pantano I; Riccardi A; Afeltra A; Valentini G
    Lupus; 2017 Dec; 26(14):1463-1472. PubMed ID: 28786768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Impact of Statins on the Lipid Profile and Cardiovascular Risk in Patients With Systemic Lupus Erythematosus: Systematic Review of the Literature and a Meta-analysis.
    Sánchez P; Toro-Trujillo E; Muñoz-Velandia OM; García AA; Fernández-Ávila DG
    Reumatol Clin (Engl Ed); 2019; 15(6):e86-e91. PubMed ID: 29428197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins and lupus erythematosus.
    Noël B
    Rheumatology (Oxford); 2004 Mar; 43(3):397-8; author reply 398-9. PubMed ID: 14963215
    [No Abstract]   [Full Text] [Related]  

  • 7. Statins in systemic lupus erythematosus.
    Abud-Mendoza C
    Ann Rheum Dis; 2018 Sep; 77(9):e60. PubMed ID: 28993343
    [No Abstract]   [Full Text] [Related]  

  • 8. Response to: 'Statins in systemic lupus erythematosus' by Abud-Mendoza.
    de Jong HJI; van Staa TP; Cohen Tervaert JW
    Ann Rheum Dis; 2019 May; 78(5):e43. PubMed ID: 29358283
    [No Abstract]   [Full Text] [Related]  

  • 9. Statins for prevention of cardiovascular disease in systemic lupus erythematosus.
    Yousef Yengej FA; Limper M; Leavis HL
    Neth J Med; 2017 Apr; 75(3):99-105. PubMed ID: 28469051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should all patients with systemic lupus erythematosus receive cardioprotection with statins?
    Toloza S; Urowitz MB; Gladman DD
    Nat Clin Pract Rheumatol; 2007 Oct; 3(10):536-7. PubMed ID: 17700557
    [No Abstract]   [Full Text] [Related]  

  • 11. [Assessing the cardiovascular risk in patients with systemic lupus erythematosus].
    Arnaud L; Mathian A; Bruckert E; Amoura Z
    Rev Med Interne; 2014 Nov; 35(11):723-9. PubMed ID: 25234464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular Disease in Patients With Systemic Lupus Erythematosus: Potential for Improved Primary Prevention With Statins.
    Ballarano CA; Frishman WH
    Cardiol Rev; 2021 Nov-Dec 01; 29(6):323-327. PubMed ID: 34609986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lupus erythematosus and other autoimmune diseases related to statin therapy: a systematic review.
    Noël B
    J Eur Acad Dermatol Venereol; 2007 Jan; 21(1):17-24. PubMed ID: 17207162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy Insight: cardiovascular disease in pediatric systemic lupus erythematosus.
    Sandborg C; Ardoin SP; Schanberg L
    Nat Clin Pract Rheumatol; 2008 May; 4(5):258-65. PubMed ID: 18349862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Statin Therapy in Patients with Systemic Lupus Erythematosus.
    Artola RT; Mihos CG; Santana O
    South Med J; 2016 Nov; 109(11):705-711. PubMed ID: 27812716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual effects of statins therapy in systemic lupus erythematosus and SLE-related atherosclerosis: the potential role for regulatory T cells.
    Tu H; Li Q; Xiang S; Jiang H; Mao Y; Shou Z; Chen J
    Atherosclerosis; 2012 May; 222(1):29-33. PubMed ID: 22417842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of statins in the prevention of atherosclerosis in patients with systemic lupus erythematosus--a meta-analysis of randomized controlled trials.
    Ye Y; Zhao X; Xie H; Tian Z; Zhang S
    Int J Cardiol; 2013 Jul; 167(1):301-3. PubMed ID: 23084817
    [No Abstract]   [Full Text] [Related]  

  • 18. Statins: immunomodulators for autoimmune rheumatic disease?
    Jury EC; Ehrenstein MR
    Lupus; 2005; 14(3):192-6. PubMed ID: 15807195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular disease in lupus patients: should all patients be treated with statins and aspirin?
    Bruce IN
    Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):823-38. PubMed ID: 16150405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Premature atherosclerosis-related central nervous system involvement in two cases of systemic lupus erythematosus.
    Zhang X; Tian X; Zhang F
    J Clin Rheumatol; 2007 Aug; 13(4):211-2. PubMed ID: 17762456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.